Paula T. Einhorn - Concepedia

Author

Paula T. Einhorn

National Heart Lung and Blood Institute

Also Known As

P Einhorn, PAULA T. EINHORN, Paula Einhorn, Paula T Einhorn, Paula T. Einhorn, Paula Turyn Einhorn, Ray Ebert

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

National Heart Lung and Blood Institute The University of Texas Health Science Center at Houston University of Alabama at Birmingham Kaiser Permanente Tulane University

About

Paula T. Einhorn is an author at National Heart Lung and Blood Institute specializing in medicine, cardiovascular disease, and hypertension.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	484
2	Public Health	7	7	320
3	Emergency Medicine	4	4	341
4	Diabetes	1	1	22
5	Endocrinology	1	1	23

Paula T. Einhorn

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial Valery T. Miller, John C. LaRosa, Vanessa M. Barnabei, JAMA	1995	605
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality Paul Muntner, Jeff Whittle, Amy I. Lynch, Annals of Internal Medicine	2015	301
Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Barry R. Davis, John B. Kostis, Lara M. Simpson, Circulation	2008	204
Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) L. Julian Haywood, Charles E. Ford, Richard S. Crow, Journal of the American College of Cardiology HypertensionLipid-lowering TreatmentCardiovascular DiseaseCardiovascular PharmacologyHeart Attack Trial	2009	180
Blood Pressure Control by Drug Group in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) William C. Cushman, Charles E. Ford, Paula T. Einhorn, Journal of Clinical Hypertension	2008	88
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone Linda B. Piller, Barry R. Davis, Jeffrey A. Cutler, Current Controlled Trials in Cardiovascular Medicine	2002	77
Clinical Significance of Incident Hypokalemia and Hyperkalemia in Treated Hypertensive Patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Michael H. Alderman, Linda B. Piller, Charles E. Ford, Hypertension HypertensionHyperkalemia IncidenceElectrolyte DisorderCardiovascular PharmacologyPharmacotherapy	2012	72
Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension Joshua I. Barzilay, Barry R. Davis, Sara Pressel, Circulation Cardiovascular Quality and Outcomes	2012	70
The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) heart failure Validation Study: Diagnosis and prognosis Paula T. Einhorn, Barry R. Davis, Barry M. Massie, American Heart Journal HypertensionHeart FailureCardiovascular DiseaseAntihypertensive TherapyHeart Attack Trial	2006	69
Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults Rachel Puttnam, Barry R. Davis, Sara Pressel, JAMA Internal Medicine	2016	66

Page 1